We all appreciate the impact of meibomian gland disease (MGD) on the ocular surface and eyelids. Treatment should be initiated as early as possible to minimize gland necrosis and drop out. The protocol isn’t rocket science. If you have advanced technologies that can be used in office, such as LipiFlow, Tear Care, IPL, or other […]

Read More… from Randall Fuerst OD Discusses EyeGiene Value to Optometry Practice